Urologic Health

Company Overview

Snapshot

Founded in September 2024 by Adam Yaacov and Noam Omer, Urologic Health operates with 1–10 employees. The company has raised $11 million across one funding round from two investors. In May 2026, Urologic Health secured $11 million in Seed financing to advance its non-invasive bladder function monitoring platform.

Business overview

Urologic Health develops the niu System, a non-invasive urodynamic diagnostic platform designed for clinicians to assess bladder dysfunction. This technology captures bladder activity and converts it into clinically meaningful diagnostic data without requiring catheterization. The system aims to provide a more repeatable and patient-friendly workflow for urologists evaluating conditions such as overactive bladder, urinary retention, incontinence, and benign prostatic hyperplasia (BPH). The company operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Diagnostics Devices, and serves the healthcare market, particularly providers, in geomarkets including the United States and Israel.

Strategic signal

In May 2026, Urologic Health announced an $11 million Seed financing round. This capital infusion signals strong investor confidence in the company's non-invasive bladder function monitoring technology, the niu System, and its potential to address significant unmet needs in urology care. The funding is expected to accelerate the development and commercialization of a patient-friendly diagnostic solution, positioning Urologic Health for further growth in the medical device and diagnostics market.

Company Intelligence Q&A

What is Urologic Health's primary focus?

Urologic Health focuses on developing non-invasive bladder function diagnostics for urology care, specifically through its niu System platform.

When was Urologic Health founded and by whom?

Urologic Health was founded in September 2024 by Adam Yaacov and Noam Omer.

What is the niu System?

The niu System is a non-invasive urodynamic diagnostic platform developed by Urologic Health to capture bladder activity and convert it into clinically meaningful diagnostic data without catheterization, aiding in the assessment of bladder dysfunction.

What was Urologic Health's most recent funding event?

In May 2026, Urologic Health announced an $11 million Seed financing round to advance its non-invasive bladder function monitoring technology. This round included investment from Longevity Venture Partners and Edge Medical Ventures.

Which markets does Urologic Health serve?

Urologic Health serves geomarkets including the United States and Israel, focusing on the healthcare sector and providers.